What are the causes of relative lymphocytosis in a patient with gastro‑oesophageal reflux disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Relative Lymphocytosis in GERD Patients

Relative lymphocytosis in a patient with GERD most commonly represents lymphocytic esophagitis (LE), a distinct pattern of esophageal inflammation characterized by increased intraepithelial lymphocytes (typically >40 lymphocytes per high-power field) with minimal granulocytic infiltration. This is one of the major patterns of lymphocytic inflammation seen in GERD patients 1.

Understanding the Lymphocytic Response in GERD

The esophageal mucosa in GERD patients demonstrates significant lymphocytic infiltration that has been historically underappreciated. Studies show that both GERD and eosinophilic esophagitis patients have substantial numbers of lymphocytes (GERD: 22.7±2.2/HPF vs EoE: 19.8±1.8/HPF), with no significant difference between the two conditions 2.

Three Major Patterns of Lymphocytic Inflammation in GERD:

  1. Lymphocytic esophagitis (LE) - occurs in 6.8% of GERD patients, typically focal, with peripapillary lymphocytosis and rare granulocytes 1

  2. Dispersed lymphocytes in areas of reflux esophagitis - seen in 5.6% of patients, typically diffuse 1

  3. Peripapillary lymphocytes within reflux esophagitis - least common at 1.2% 1

Key Diagnostic Features

The lymphocytic infiltrate in GERD-associated LE is predominantly CD8+ T-cell mediated. CD8 T cells significantly outnumber CD4 T cells in 91% of patients with lymphocytic esophagitis and 100% of patients with dispersed lymphocytes in reflux esophagitis 1. This CD8 T-cell predominance may serve as a useful marker of GERD in the differential diagnosis of LE.

Immunologic Mechanisms

Acid-induced T-cell-related cytokine production plays a central role in the inflammatory response. Studies demonstrate:

  • Very high numbers of infiltrating B cells (700±30/10 HPF) forming large aggregations
  • Moderate T-cell infiltration (570±23/10 HPF) forming smaller aggregates
  • Elevated inflammatory cytokines (IL-8, IL-1β) in more severe GERD (Los Angeles grades B, C, D) 3

Response to Acid Suppression

Treatment with proton pump inhibitors (PPIs) significantly reduces both mucosal and peripheral lymphocyte counts in approximately 66% of patients 3. After one month of PPI therapy:

  • B cells decrease dramatically (to 10±2/10 HPF)
  • T cells decrease substantially (to 290±12/HPF)
  • Peripheral blood CD3+, CD4+, and CD8+ T-lymphocyte counts all decrease significantly 3

However, 33% of patients show persistent lymphocytosis despite PPI therapy, with T cells remaining elevated (490±28/HPF), indicating ongoing activation 3.

Clinical Implications and Differential Diagnosis

When to Suspect Lymphocytic Esophagitis:

  • Patient demographics: Predominantly older women or patients with immunologic abnormalities (Crohn disease, rheumatologic disorders, common variable immunodeficiency) 4
  • Presenting symptoms: Dysphagia is most common, but can include chest pain, food bolus impaction 5, 6
  • Endoscopic findings: May appear normal ("microscopic esophagitis") or show changes mimicking eosinophilic esophagitis (edema, rings, furrows, plaques) 4

Critical Distinction from Other Conditions:

The diagnosis requires biopsy confirmation showing intraepithelial lymphocytosis without significant granulocytic inflammation and evidence of epithelial damage 4. This distinguishes it from:

  • Eosinophilic esophagitis (prominent eosinophils)
  • Candida infection (fungal elements)
  • Other causes of esophageal lymphocytosis 5

Management Approach

Initiate high-dose PPI therapy as first-line treatment 6. The response to acid suppression helps confirm the GERD-related nature of the lymphocytosis:

  • Approximately 5% of GERD specimens meet histopathological criteria for LE, potentially blurring the line between these entities 2
  • Patients using antireflux medications show fewer lymphocytes (16.3±1.3 vs 22.2±2.3/HPF) and reduced inflammation 2
  • Follow-up endoscopy is recommended to monitor treatment response 6

Important Caveats:

  • The inverse correlation between eosinophils and lymphocytes in eosinophilic esophagitis (R=-0.47) but not in GERD (R=0.18) suggests different pathophysiologic mechanisms 2
  • Persistent lymphocytosis despite adequate acid suppression may indicate a chronic inflammatory disorder requiring alternative approaches 4
  • The presence of luminal strictures and persistent dysphagia in some patients provides evidence that LE can be a chronic condition requiring long-term management 4

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.